This report provides exclusive insights into the COVID-19 impact on the Fetal Bovine Serum Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Fetal Bovine Serum Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Fetal Bovine Serum Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by Infinium Global Research on fetal
bovine serum market provides an in-depth analysis of segments and sub-segments in
global as well as regional fetal bovine serum market. The study also highlights
the impact of drivers, restraints and macro indicators on the global and
regional fetal bovine serum market over the short term as well as long term.
The report is a comprehensive presentation of trends, forecast and dollar
values of global fetal bovine serum market. According to the report the global
fetal bovine serum market is projected to grow at a CAGR of 8.0% over the
forecast period of 2018-2024.
FBS is a by-product of the meat
processing industry a critical raw material for much of the biotechnology,
pharmaceutical and diagnostics industry. FBS is obtained from whole blood
obtained from normal bovine fetuses. Fortify cell culture media is the primary
application of fetal bovine serum (FBS). Fetal bovine serum is important for innovative
research in drug development. FBS has wide applications in cell-based research,
diagnostics, drug discovery, cell therapy, toxicity testing, in vitro
fertilization, human and animal vaccine production, and biopharmaceutical
Research and development efforts
in the commercial and academic sectors continue to depend on fetal bovine serum
as a safe and effective growth medium. Growing demand from traditional serum
users is likely to boost the growth of the market. Growth in the number of academic
research institutes and government collaboration with the academic research
institutes to support research activities are likely driving the demand for
fetal bovine serum. On the other hand, due to unfavorable climatic conditions such
as drought, and growing beef and dairy demand has led to an extreme drop in
cattle herd population. Thus affecting the demand for FBS. Furthermore,
increasing customer’s interest in qualifying serum from several global regions,
this change will provide flexibility to companies for adjusting their serum
sourcing in terms of price and availability.
In terms of regions, North
America is expected to be the largest market for fetal bovine serum. The high
consumption and high pricing of fetal bovine serum in the region. The US is
the biggest market for FBS. Growing demand, together with a lower supply has
led to a volatile market for the U.S. The rapid emergence of contract research
organizations particularly in India and China is a key factor driving the
growth of Asia-Pacific region. Moreover, Infrastructural development and number
of research organizations are outsourcing research activities to these
countries for a relatively low cost without negotiating on the quality of
The report on global fetal bovine serum market covers segments
such as application type and end user.
On the basis of application type, the global fetal bovine serum market is
categorized into drug discovery, cell culture media, in vitro fertilization,
human and animal vaccine production, diagnostics and others. On the basis of
end user the global fetal bovine serum market is categorized into research
& academic institutes and industry.
The report provides regional analysis covering geographies such
as North America, Europe, Asia-Pacific, and Rest of the World. In this section, the key trends and market size for each geography are provided over the period
of 2016-2024. The countries covered in the North America region include the
U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India,
South Korea, Malaysia, and among others. Moreover, Germany, U.K., France,
Spain and Rest of Europe are included in the European region. The U.S. drives
the growth in the North America region as it is the largest market in the
region. The Asia-pacific region offers a substantial potential for the market
growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a
growth at a CAGR of x.x% over the period of 2018-2024.
The report provides profiles of the companies in the global
fetal bovine serum market such as HiMedia Laboratories, Merck KGaA, Bovogen
Biologicals Pty Ltd, Atlanta Biologicals Inc., TCS Biosciences Ltd, Tissue
Culture Biologicals, Rocky Mountain Biologicals, GE Healthcare, and Others.
The report provides deep insights on demand forecasts, market
trends, and micro and macro indicators. In addition, this report provides
insights into the factors that are driving and restraining the global fetal
bovine serum market. Moreover, IGR-Growth Matrix analysis given in the report
brings an insight into the investment areas that existing or new market players
can consider. The report provides insights into the market using analytical
tools such as Porter's five forces analysis and DRO analysis of fetal bovine
serum market. Moreover, the study highlights current market trends and provides
forecast from 2018-2024. We also have highlighted future trends in the fetal
bovine serum market that will impact the demand during the forecast period.
Moreover, the competitive analysis given in each regional market brings an
insight on the market share of the leading players. This report will help
manufacturers, suppliers, and distributors of the fetal bovine serum market to
understand the present and future trends in this market and formulate their